Research & Education

Research, education and patient care form the three-part mission of the OSUCCC – James. The three are tightly intertwined and focused on one goal: creating a cancer-free world.

The OSUCCC – James is one of only 45 comprehensive cancer centers in the nation as designated by the National Cancer Institute (NCI), a designation that we have maintained through competitive renewal since 1976. After the site review for our last renewal, we earned the NCI's highest ranking, "exceptional," and received a five-year, $23 million NCI support grant. The NCI survey team stated that the OSUCCC – James "should serve as the model for other matrix university-based centers."

More than 200 researchers from 12 of 15 colleges across The Ohio State University campus are members of the OSUCCC – James. Each member belongs to one or more of five OSUCCC – James research programs. Specialized technology and expertise needed for particular studies are available through the 20 Shared Resources and Cores at the OSUCCC – James. OSUCCC – James investigators are working to develop novel, innovative approaches to preventing, diagnosing and treating cancer and to understanding the disease in its many forms. Interesting research collaborations involving investigators from diverse colleges are the result.

Care of cancer patients is provided at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, the patient care component of The Ohio State University Comprehensive Cancer Center. The hospital is staffed by nationally and internationally known physicians, physician-researchers, nurses and staff who provide compassionate, state-of-the-art care. The laboratories and education centers support Ohio State’s new College of Medicine curriculum, which involves even first-year medical students in patient care. Research activities in patient-care areas should also foster medical students’ interest in research.

The OSUCCC – James provides numerous opportunities for the continuing education of its clinical and research faculty, trainees and students. In addition, competitive, two-year Pelotonia fellowships are available to undergraduate students, graduate students, medical students and post-doctoral trainees who are interested in cancer research.

Research Programs

Learn about the highly-interactive cancer research programs led by OSUCCC – James experts that span the spectrum from basic science to clinical trials.

Read More

Clinical Research

Obtain information about clinical research and clinical trials being conducted at the OSUCCC – James to improve cancer prevention, detection and treatment.

Read More

Shared Resources

Learn about the 20 Shared Resources that provide specialized services to cancer researchers. They offer cost-effective, state-of-the-art technology and instrumentation; expert guidance and training; and clinical, administrative and technical support.

Read More

Major Cancer Research Grants

Access information about grant-funded research at the OSUCCC – James to advance the prevention, detection and treatment of cancer.

Read More

Pelotonia Funded Research

Learn about research at the OSUCCC – James funded by Pelotonia, the annual grassroots bike tour that generates money for cancer research at Ohio State.

Read More

Genomics, Sequencing & Tissue Banking

Learn about how genome sequencing and tissue banking at the OSUCCC – James is furthering cancer research and the development of targeted therapies.

Read More

Labs and Facilities

Learn about the labs and facilities at the OSUCCC – James that are conducting groundbreaking research to improve cancer prevention, detection and treatment.

Read More

Drug Development Institute

Access information about how the Drug Development Institute at the OSUCCC – James is taking novel therapies to market to improve cancer care and treatment.

Read More

Education and Development

Learn about continuing medical education events at the OSUCCC – James that can help healthcare professionals provide enhanced patient care and outcomes.

Read More

Research Standards and Quality

Learn about the standards for physicians and researchers at the OSUCCC – James and how they improve survival and quality of life for cancer patients.

Read More

Find a Researcher

More than 250 cancer researchers translate laboratory and clinical studies into innovative care that leads to optimal patient outcomes.

Read More

Find a Scientific Publication

Learn more about scientific publications authored by cancer research experts at the OSUCCC – James on topics including cancer prevention, detection & treatment.

Read More

Intramural Research Program

The Ohio State University Comprehensive Cancer Center (OSUCCC) is now accepting applications for the Fall 2015 Intramural Research Awards Program (IRP), which includes the Pelotonia Research Awards Program and other funding sources. In the spring of this year, we funded seven grants. The funding opportunities for OSUCCC – James investigators include five award categories and can be downloaded here:

-- Bridge
-- Clinical Trial
-- Community
-- Idea
-- Team Science

Applications must be submitted no later than Monday, Aug. 24, 2015, by 12 p.m. EST.

If you have any questions or need additional information, please contact Chris Scarcello at 614-293-4150.

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Find a Scientific Publication

Latest News

Support Those Who Support Us – October 2015

The OSUCCC – James is so grateful to the more than 400 partners who raise dollars to support care for our patients & the research that is bringing us closer to our shared vision of a cancer-free world.

The Spielman Fund: Allocating Dollars Where They Are Needed Most

When donors contribute to the Spielman Fund, they can trust that their gift will make an important and strategic impact.

Studies Suggest New Ways to Inhibit Oncogenes, Enhance Tumor-Suppressor Activity

Two new studies by OSUCCC - James cancer scientists suggest new approaches for treating cancer by inhibiting overactive cancer-promoting genes and by enhancing the activity of sluggish tumor-suppressor...